US Pharma MarketingUK on track to reverse years of pharma decline, ABPI report finds - Pharmaceutical Technology
The UK remains competitive in its science, but experts say more must be done to incentivise investment into Britain as global rivalry mounts. The UK remains competitive in its science, but experts say more must be done to incentivise investment into Britain as global rivalry mounts. While the ABPI points to some positive signs for the UK’s competitiveness in pharma, the trade notes there are still multiple hurdles to overcome for Britain to realise its potential. Credit: SsCreativeStudio / Shutterstock.com. The UK could be set to enter a pharma renaissance after a tricky few years punctuated with withdrawn investments, a…
The UK remains competitive in its science, but experts say more must be done to incentivise investment into Britain as global rivalry mounts.
Source: Pharmaceutical Technology